The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting
File(s)1-s2.0-S0168822717313359-main.pdf (663.37 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Aims
Studies addressing the association between diabetes mellitus (DM) and tuberculosis (TB) in sub–Saharan Africa are limited. We assessed the prevalence of active TB among DM patients at a primary care clinic, and identified risk factors for prevalent TB.
Methods
A cross–sectional study was conducted in adult DM patients attending a clinic in Khayelitsha, Cape Town. Participants were screened for active TB (symptom screening and microbiological diagnosis) and HIV.
Results
Among 440 DM patients screened, the active TB prevalence was 3.0% (95% CI 1.72–5.03). Of the 13 prevalent TB cases, 53.9% (n=7; 95% CI 27.20–78.50) had no TB symptoms, and 61.5% (n=8; 95% CI 33.30–83.70) were HIV–1 co–infected. There were no significant differences in either fasting plasma glucose or HbA1c levels between TB and non–TB participants. On multivariate analysis, HIV–1 infection (OR 11.3, 95% CI 3.26–39.42) and hemoptysis (OR 31.4, 95% CI 3.62– 273.35) were strongly associated with prevalent active TB, with no differences in this association by age or gender.
Conclusions
The prevalence of active TB among DM patients was 4–fold higher than the national prevalence; suggesting the need for active TB screening, particularly if hemoptysis is reported. Our results highlight the importance of HIV screening in this older population group. The high prevalence of sub–clinical TB among those diagnosed with TB highlights the need for further research to determine how best to screen for active TB in high–risk TB/HIV population groups and settings.
Studies addressing the association between diabetes mellitus (DM) and tuberculosis (TB) in sub–Saharan Africa are limited. We assessed the prevalence of active TB among DM patients at a primary care clinic, and identified risk factors for prevalent TB.
Methods
A cross–sectional study was conducted in adult DM patients attending a clinic in Khayelitsha, Cape Town. Participants were screened for active TB (symptom screening and microbiological diagnosis) and HIV.
Results
Among 440 DM patients screened, the active TB prevalence was 3.0% (95% CI 1.72–5.03). Of the 13 prevalent TB cases, 53.9% (n=7; 95% CI 27.20–78.50) had no TB symptoms, and 61.5% (n=8; 95% CI 33.30–83.70) were HIV–1 co–infected. There were no significant differences in either fasting plasma glucose or HbA1c levels between TB and non–TB participants. On multivariate analysis, HIV–1 infection (OR 11.3, 95% CI 3.26–39.42) and hemoptysis (OR 31.4, 95% CI 3.62– 273.35) were strongly associated with prevalent active TB, with no differences in this association by age or gender.
Conclusions
The prevalence of active TB among DM patients was 4–fold higher than the national prevalence; suggesting the need for active TB screening, particularly if hemoptysis is reported. Our results highlight the importance of HIV screening in this older population group. The high prevalence of sub–clinical TB among those diagnosed with TB highlights the need for further research to determine how best to screen for active TB in high–risk TB/HIV population groups and settings.
Date Issued
2018-04-01
Date Acceptance
2018-01-23
Citation
Diabetes Research and Clinical Practice, 2018, 138, pp.16-25
ISSN
0168-8227
Publisher
Elsevier
Start Page
16
End Page
25
Journal / Book Title
Diabetes Research and Clinical Practice
Volume
138
Copyright Statement
© 2018 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/
License URL
Sponsor
Wellcome Trust
Wellcome Trust
Wellcome Trust
Grant Number
097816/Z/11/ZR
097816/Z/11/B
104803/Z/14/ZR
Subjects
1103 Clinical Sciences
Endocrinology & Metabolism
Publication Status
Published
Date Publish Online
2018-01-31